Novel metal complexes of naphthalimide-cyclam conjugates as potential multi-target receptor tyrosine kinase (RTK) inhibitors: Synthesis and biological evaluation
文献类型：期刊论文
| 作者 | Tan, Shaoying1; Han, Kun2; Li, Qiang1; Tong, Linjiang2; Yang, Yiqi1; Chen, Zhuo1; Xie, Hua2 ; Ding, Jian2; Qian, Xuhong1; Xu, Yufang1
|
| 刊名 | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
 |
| 出版日期 | 2014-10-06 |
| 卷号 | 85页码:207-214 |
| 关键词 | Metal complexes Naphthalimide Cyclam RTK inhibitors Antiproliferation Antiangiogenesis |
| ISSN号 | 0223-5234 |
| DOI | 10.1016/j.ejmech.2014.07.068 |
| 文献子类 | Article |
| 英文摘要 | A novel series of metal complexes of naphthalimide-cyclam conjugates were synthesized and their in vitro antitumor activities were evaluated. The newly-synthesized compounds showed huge diversity of antiproliferative potency due to variety of metal ions and length of alkyl chains, among which the Zn(II) and Cr(III) complexes exhibited comparable antiproliferative activities with amonafide via multiple tyrosine kinase inhibition. Further research revealed that the representative compound 8a displayed broad-spectrum antiproliferative activity against 15 cancer cell lines with average IC50 value 10.18 +/- 3.25 mu M, and effective antiangiogenic activity on human microvascular endothelial cells (HMEC-1). In brief, metal complexes of naphthalimide-cyclam conjugates were firstly designed and synthesized as multi-target tyrosine kinase inhibitors and proved of their antitumor capacities. (C) 2014 Elsevier Masson SAS. All rights reserved. |
| WOS关键词 | RENAL-CELL CARCINOMA ; CANCER-THERAPY ; GROWTH-FACTOR ; TOPOISOMERASE-II ; ANTITUMOR AGENTS ; IN-VITRO ; DERIVATIVES ; ANGIOGENESIS ; STRATEGIES ; SU11248 |
| 资助项目 | National Basic Research Program of China (973 Program)[2010CB126100] ; National High Technology Research and Development Program of China (863 Program)[2011AA10A207] ; National Natural Science Foundation of China[21236002] ; National Natural Science Foundation of China[21302054] ; National Science & Technology Pillar Program[00000000] ; Shanghai Committee of Science and Technology[13ZR1453100] ; Fundamental Research Funds for the Central Universities[00000000] |
| WOS研究方向 | Pharmacology & Pharmacy |
| 语种 | 英语 |
| WOS记录号 | WOS:000342859700017 |
| 出版者 | ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/276872]  |
| 专题 | 药理学第一研究室 中科院受体结构与功能重点实验室 新药研究国家重点实验室 |
| 通讯作者 | Chen, Zhuo |
| 作者单位 | 1.E China Univ Sci & Technol, Shanghai Key Lab New Drug Design, Shanghai Key Lab Chem Biol, State Key Lab Bioreactor Engn,Sch Pharm, Shanghai 200237, Peoples R China; 2.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Div Antitumor Pharmacol, Shanghai 201203, Peoples R China |
| 推荐引用方式 GB/T 7714 | Tan, Shaoying,Han, Kun,Li, Qiang,et al. Novel metal complexes of naphthalimide-cyclam conjugates as potential multi-target receptor tyrosine kinase (RTK) inhibitors: Synthesis and biological evaluation[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,2014,85:207-214. |
| APA | Tan, Shaoying.,Han, Kun.,Li, Qiang.,Tong, Linjiang.,Yang, Yiqi.,...&Xu, Yufang.(2014).Novel metal complexes of naphthalimide-cyclam conjugates as potential multi-target receptor tyrosine kinase (RTK) inhibitors: Synthesis and biological evaluation.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,85,207-214. |
| MLA | Tan, Shaoying,et al."Novel metal complexes of naphthalimide-cyclam conjugates as potential multi-target receptor tyrosine kinase (RTK) inhibitors: Synthesis and biological evaluation".EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 85(2014):207-214. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。